Who owns Lineage Cell Therapeutics In?
- Ticker: LCTX
- CUSIP Number: 53566p109
Tip: Access positions for across all investors
Analyze quarterly positions in Lineage Cell Therapeutics In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lineage Cell Therapeutics In stock
Who bought or sold Lineage Cell Therapeutics In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 8.5M | $13M | -9% | Mar 2024 |
|
| Vanguard Group | 8.4M | $12M | 0% | Mar 2024 |
|
| Logos Global Management | 6.3M | $9.3M | 100% | Mar 2024 |
|
| Defender Capital | 5.0M | $7.4M | 0% | Mar 2024 |
|
| Geode Capital Management | 3.3M | $4.8M | 18% | Mar 2024 |
|
| Raffles Associates | 3.2M | $4.8M | 51% | Mar 2024 |
|
| Prescott General Partners | 1.9M | $2.7M | 0% | Mar 2024 |
|
| MAI Wealth Advisors | 1.5M | $2.2M | 85% | Mar 2024 |
|
| DAFNA Capital Management | 1.4M | $2.0M | 100% | Mar 2024 |
|
| Bank of America Corporation | 1.3M | $1.9M | 5397% | Mar 2024 |
|
| Northern Trust | 1.2M | $1.8M | 2% | Mar 2024 |
|
| Bridgeway Capital Management | 682k | $1.0M | -13% | Mar 2024 |
|
| Jpmorgan Chase & Co | 676k | $1.0M | -7% | Mar 2024 |
|
| Nuveen Asset Management | 515k | $763k | 0% | Mar 2024 |
|
| Morgan Stanley | 459k | $678k | 65% | Mar 2024 |
|
| Charles Schwab Investment Management | 366k | $542k | 1% | Mar 2024 |
|
| Bank of New York Mellon | 321k | $475k | -10% | Mar 2024 |
|
| Brian McDonald | 250k | $370k | 84746% | Mar 2024 |
|
| Citadel Advisors | 243k | $359k | -59% | Mar 2024 |
|
| Long Focus Capital Management | 215k | $318k | 0% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 206k | $305k | 27% | Mar 2024 |
|
| Squarepoint Ops | 192k | $284k | 11% | Mar 2024 |
|
| D. E. Shaw & Co | 187k | $276k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 161k | $239k | 77% | Mar 2024 |
|
| UBS Group | 140k | $210k | -3% | Mar 2024 |
|
| Rhumbline Advisers | 115k | $170k | 3% | Mar 2024 |
|
| DCF Advisers | 108k | $160k | 30% | Mar 2024 |
|
| Jane Street | 105k | $155k | -36% | Mar 2024 |
|
| Williams Jones Wealth Management | 101k | $150k | 0% | Mar 2024 |
|
| Barclays | 94k | $139k | -49% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 75k | $111k | -2% | Mar 2024 |
|
| MetLife Investment Advisors | 69k | $75k | 0% | Dec 2023 |
|
| American International | 66k | $72k | 2% | Dec 2023 |
|
| HighTower Advisors | 64k | $95k | 18% | Mar 2024 |
|
| Wells Fargo & Company | 60k | $89k | -1% | Mar 2024 |
|
| Ing Investment Management | 48k | $71k | -15% | Mar 2024 |
|
| Commonwealth Equity Services | 48k | $71k | 0% | Mar 2024 |
|
| CIBC World Markets | 46k | $68k | 0% | Mar 2024 |
|
| Beirne Wealth Consulting Services | 45k | $67k | 0% | Mar 2024 |
|
| United Bank | 42k | $62k | 41% | Mar 2024 |
|
| Millennium Management | 42k | $62k | -28% | Mar 2024 |
|
| LPL Financial | 42k | $61k | -57% | Mar 2024 |
|
| Dimensional Fund Advisors | 40k | $60k | 0% | Mar 2024 |
|
| Susquehanna International | 35k | $52k | 143% | Mar 2024 |
|
| Rathbones Brothers | 35k | $52k | 0% | Mar 2024 |
|
| Trust Co Of Toledo Na | 34k | $50k | 0% | Mar 2024 |
|
| Two Sigma Advisers | 32k | $48k | -15% | Mar 2024 |
|
| Fort Sheridan Advisors | 32k | $48k | -62% | Mar 2024 |
|
| Goldman Sachs Group | 27k | $39k | -29% | Mar 2024 |
|
| Creative Planning | 26k | $39k | 0% | Mar 2024 |
|
| Citigroup | 26k | $38k | 8% | Mar 2024 |
|
| Victory Capital Management | 25k | $37k | 5% | Mar 2024 |
|
| ProShare Advisors | 24k | $35k | 42% | Mar 2024 |
|
| Ameriprise Financial | 24k | $35k | -8% | Mar 2024 |
|
| PFG Investments | 21k | $31k | 5% | Mar 2024 |
|
| Raymond James & Associates | 20k | $30k | 0% | Mar 2024 |
|
| Fifth Third Wealth Advisors | 20k | $30k | 100% | Mar 2024 |
|
| Allegheny Financial Group | 20k | $30k | 0% | Mar 2024 |
|
| Pine Valley Investments Ltd Liability | 18k | $27k | 100% | Mar 2024 |
|
| Principal Financial Group | 18k | $26k | 9% | Mar 2024 |
|
| Alliancebernstein | 18k | $19k | 0% | Dec 2023 |
|
| Mariner Wealth Advisors | 17k | $25k | 13% | Mar 2024 |
|
| Scotia Capital | 17k | $18k | 0% | Dec 2023 |
|
| Straight Path Wealth Management | 16k | $24k | 0% | Mar 2024 |
|
| Legal & General Group | 16k | $23k | 0% | Mar 2024 |
|
| Madrona Financial Services | 15k | $22k | 0% | Mar 2024 |
|
| SkyOak Wealt | 15k | $22k | 0% | Mar 2024 |
|
| Thrivent Financial for Lutherans | 15k | $22k | 0% | Mar 2024 |
|
| Quadrant Private Wealth Management | 15k | $22k | 50% | Mar 2024 |
|
| Beacon Capital Management | 15k | $22k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 13k | $20k | -53% | Mar 2024 |
|
| Qube Research & Technologies | 13k | $19k | 100% | Mar 2024 |
|
| Lafayette Investments | 13k | $19k | 0% | Mar 2024 |
|
| Piscataqua Savings Bank | 13k | $19k | 0% | Mar 2024 |
|
| ELCO Management | 12k | $13k | 0% | Dec 2023 |
|
| Farrow Financial | 12k | $17k | -32% | Mar 2024 |
|
| Summit Investment Advisors | 11k | $16k | 0% | Mar 2024 |
|
| Summit Trail Advisors | 10k | $15k | 100% | Mar 2024 |
|
| Riggs Asset Managment | 9.6k | $14k | 0% | Mar 2024 |
|
| Lazard Asset Management | 9.4k | $0 | 7% | Dec 2023 |
|
| Founders Capital Management | 8.0k | $12k | 0% | Mar 2024 |
|
| Simplex Trading | 6.3k | $9.0k | -34% | Mar 2024 |
|
| Hanson McClain Advisors | 4.8k | $7.0k | 0% | Mar 2024 |
|
| Amalgamated Bank | 4.4k | $6.0k | -76% | Mar 2024 |
|
| New York State Common Retirement Fund | 3.3k | $5.0k | 4% | Mar 2024 |
|
| Royal Bank of Canada | 3.1k | $0 | -98% | Mar 2024 |
|
| Albion Financial Group | 3.0k | $4.5k | 0% | Mar 2024 |
|
| Pacifica Partners | 2.9k | $3.7k | 0% | Mar 2024 |
|
| FMR | 2.1k | $3.1k | 45% | Mar 2024 |
|
| Advisor Group Holdings | 2.1k | $3.1k | -5% | Mar 2024 |
|
| CWM | 1.5k | $2.0k | 100% | Mar 2024 |
|
| Tower Research Capital | 972.00 | $1.4k | -91% | Mar 2024 |
|
| BFSG | 355.00 | $526.003500 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 321.00 | $475.015800 | 7% | Mar 2024 |
|
| Planning Capital Management Corp | 100.00 | $148.000000 | 0% | Mar 2024 |
|
| First Manhattan | 94.00 | $138.997800 | 0% | Mar 2024 |
|
| Coppell Advisory Solutions | 63.00 | $68.997600 | -61% | Dec 2023 |
|
| Covestor | 33.00 | $0 | 100% | Mar 2024 |
|
| Lindbrook Capital | 29.00 | $43.001200 | -98% | Mar 2024 |
|
| Central Trust & Investment | 29.00 | $43.001200 | 0% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 14.00 | $14.999600 | 0% | Dec 2023 |
|
| Newbridge Financial Services Group | 5.00 | $7.000000 | 0% | Mar 2024 |
|
| Plante Moran Financial Advisors | 2.00 | $3.000000 | 0% | Mar 2024 |
|
| D. J. St. Germain | 2.00 | $2.000000 | 0% | Dec 2023 |
|
Who sold out of Lineage Cell Therapeutics In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Laurion Capital Management | Dec 2023 | 434k | $473k |
| Florida State Board of Administration | Dec 2023 | 37k | $40k |
| Hrt Financial | Dec 2023 | 36k | $39k |
| SG Americas Securities | Dec 2023 | 31k | $34k |
| AE Wealth Management | Dec 2023 | 16k | $17k |
| Two Sigma Securities | Dec 2023 | 13k | $14k |
| Fisher Investments | Dec 2023 | 10k | $11k |
| Metropolitan Life Insurance Company | Sep 2023 | 7.1k | $8.4k |
| Pnc Financial Services | Dec 2023 | 180.00 | $196.002000 |
| Focused Wealth Management | Dec 2023 | 8.00 | $9.000000 |